Abstract: The oropharyngeal area can be a source of halitosis. However, the relationship between healthy tonsillar microbiota and halitosis is poorly understood. We conducted a pilot clinical study to clarify the effect of gargling with an antiseptic agent on tonsillar microbiota in patients with halitosis. Twenty-nine halitosis patients who did not have otolaryngologic disease or periodontitis were assigned randomly to one of three groups: benzethonium chloride (BZC) gargle; placebo gargle; no gargle. Concentrations of volatile sulfur compounds (VSCs) in mouth air, the organoleptic score (ORS) and tongue-coating score (TCS) were measured before and after testing. 
Introduction
Halitosis is defined as an offensive and unpleasant breath odor. It is caused by various volatile molecules, including sulfur compounds, aromatic compounds, and short-chain fatty acids. Volatile sulfur compounds (VSCs) such as methyl mercaptan (CH 3 SH), hydrogen sulfide (H 2 S) and dimethyl sulfide (CH 3 SCH 3 ) are mainly responsible for halitosis (1) .
Most instances of halitosis can be attributed to oral causes. Usually, the source of malodor is flaking cells that have been sloughed off via turnover of epidermal cells and food residue attached to the posterior dorsum of the tongue, which are degraded by the proteolytic enzymes of anaerobic bacteria. These bacteria produce VSCs via enzymatic reactions with sulfur-containing amino acids (2) .
halitosis. Approximately 3-10% of halitosis cases originate from the ENT region (3) .
The oropharynx area is adjacent to the oral cavity, and it is thought that bacterial transmission can occur between these niches (4) . VSC-producing anaerobic oral bacteria such as Porphyromonas gingivalis, Fusobacterium nucleatum and Treponema denticola can also constitute part of the oropharyngeal microbiota. The palatine tonsils are the main source of halitosis in the oropharynx area. Halitosis related to the tonsils is thought to occur because of pathologic disorders (e.g., tonsillitis, tonsillolith formation) whereby bacterial activity leads to inflammation, necrosis, or ulceration of tissue and production of malodorous gases (5) .
The relationship between the tonsils and halitosis is poorly understood. Talabian et al. reported that most oral malodor was produced within the oral cavity, whereas a minor portion was produced in the tonsillar area (6) . We hypothesized that healthy tonsils might also contribute to oral malodor because of anaerobic bacteria in the tonsillar crypts (a morphologic feature of the palatine tonsils). The tonsillar crypts can provide an anaerobic environment suitable for bacterial colonies (including VSC-producing species). In a pyrosequencing study of the digestive tract microbiome, Jensen et al. reported that the species diversity of obligate anaerobes, such as Porphyromonas and Prevotella, was greater in adults (7) .
To investigate the effect of gargling with an antiseptic agent upon both halitosis and tonsillar microbiota in the oropharyngeal region in patients with halitosis, periodontal pathogens and bacterial profiles of tonsillar microbiota were compared using the terminal-restriction fragment length polymorphism (T-RFLP) method.
Materials and Methods
Ethical approval of the study protocol The Ethics Committee of Aichi Gakuin University (Nagoya, Japan) approved the study design (approval numbers 227 and 371), and this study was entered in the ISRCTN registry (ISRCTN67671859). All subjects provided written informed consent to participate in the study.
Study design
This was a randomized, double-blind pilot study. A total of 228 patients who visited the Aichi Gakuin University Dental Hospital from October 2013 to September 2014 were enrolled. Exclusion criteria were: (i) history of antibiotic use within the past 3 months; (ii) history of otolaryngology consultation due to sinusitis, tonsillitis or tonsilloliths within the past 3 months; (iii) use of a gargling solution on the day of screening; (iv) periodontitis; (v) O'Leary's Plaque Control Record score >30%; (vi) organoleptic score (ORS) of 0; and (vii) CH 3 SH in mouth air <26 ppb (Fig. 1) .
Twenty-nine patients were selected and assigned randomly to one of three groups using computer-generated randomized numbers (simple randomization). The test group (n = 10) was instructed to gargle with 10 mL of mouthwash containing 0.004% benzethonium chloride (BZC) and artificial colorants (tartrazine and Brilliant Blue FCF) for 1 min, 4 times per day (after meals and before sleeping), for 9 days. The placebo group (n = 10) was instructed to gargle with a placebo mouthwash (sterile distilled water containing artificial colorants). The control group (n = 9) was instructed not to gargle. During the 9-day test period, all participants underwent professional mechanical tooth cleaning (PMTC) every 3 days to maintain uniform oral hygiene conditions between the three groups. Mouthwash prescriptions were provided and PMTC was undertaken by a single dentist who was different from those who carried out the clinical assessments. The oral malodor score and the tongue-coating score (TCS) were compared at baseline and at day 9.
Clinical assessments Probing pocket depth, attachment level, bleeding on probing, tooth mobility and O'Leary's Plaque Control Record score were measured to evaluate periodontal status and oral hygiene. OralChroma (Abimedical, Kawasaki, Japan) was used to measure the concentrations of VSCs (H 2 S, CH 3 SH, CH 3 SCH 3 ) in mouth air (8) . Before each analysis, the subjects were instructed to keep their mouths closed and to breathe through their noses for 60 s. A 1-mL disposable syringe was inserted into the center of each subject's oral cavity through the lips and teeth while the mouth was kept closed. After 1 mL of oral air had been aspirated with the syringe, 0.5 mL of the air was injected into the gas chromatograph. The judges rated malodor on a 0-5 scale, where a score of 0 represented an absence of odor; 1, barely noticeable odor; 2, slight malodor; 3, moderate malodor; 4, strong malodor; and 5, severe malodor (9) . The ORS was recorded using a 0-5 scale by three calibrated examiners. If the examiners provided different ORS scores, a mean score was used as the representative score for the subject. Fleiss' kappa coefficient of agreement was 0.882 for the organoleptic test. For the tongue coating test, the total area was recorded with a score from 0 to 4, where a score of 0 represented no tongue coating; 1, a thin coating of less than one third of the back of the tongue; 2, a thin coating of less than two-thirds of the tongue or less than one-third covered with a thick coating; 3, a thin coating of more than two-thirds of the tongue, or less than twothirds covered with a thick tongue coating; 4, more than two-thirds of the tongue covered with a thick coating (10) . Absence of otolaryngologic disease necessitating treatment at the baseline was confirmed by a single otolaryngologist via medical examination.
Collection of tonsillar and saliva samples, DNA extraction, and detection of periodontal pathogens Stimulated saliva samples produced by chewing paraffin gum for 5 min were collected in sterile plastic tubes (Saliva Check Lab Kit, GC Corp., Tokyo, Japan). Tonsillar samples were obtained by mucosal swabbing of the outer layer of the palatine tonsils using CultureSwab (Beckton Dickinson, Franklin Lakes, NJ, USA) after examination. DNA from the samples was extracted using QuickGene DNA Tissue Kit S (Kurabo Industries, Osaka, Japan). Real-time polymerase chain reaction (PCR) was undertaken for specific sequences to detect four periodontal pathogens: Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, and Prevotella intermedia (11) (12) (13) (14) .
T-RFLP
Amplification of the internal regions of 16S rRNA genes was carried out using a universal primer set with 8F (5′-AGA GTT TGA TYM TGG CTC AG-3′) labeled at the 5′ end with 6-carboxyfluorescein (6-FAM) and 806R (5′-GGA CTA CCR GGG TAT CTA A-3′) labeled at the 3′ end with hexachlorofluorescein (HEX), and KOD DNA polymerase (Toyobo, Osaka, Japan), as described previously (15) . Blunt-ended PCR amplicons (≈800 bp) were digested with HaeIII (New England Biolabs, Ipswich, MA, USA) for 1 h at 37°C. Capillary electrophoresis of the digested fragments was conducted using an ABI 3130 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA) (16) . Quantitative assessment of each terminal-restriction fragment (T-RF) was set to ascertain the area of each peak for all areas that contributed to the fluorescence peak pattern based on a measured value, the "peak area rate" (PAR). The 20 T-RFs with the highest mean PARs within the samples overall were selected for subsequent comparison as representative T-RFs for each type of fluorescein label. These T-RFs were assigned a number based on a combination of the type of fluorescein label and the size (e.g., F201 indicated a 6-FAM-labeled 5′ T-RF with a size of 201 bp).
Fig. 1
Flow chart of participant enrollment. Two hundred twenty-eight patients were assessed for their eligibility. Of these patients, 199 were excluded; 187 patients did not meet the inclusion criteria, while 12 declined to participate. Twenty-nine patients were enrolled in the study and were randomly assigned to one of three groups using computer-generated randomized numbers. No participants were excluded after enrolment.
Cloning and sequencing
The 16S rRNA clone libraries of tonsillar microbiota were obtained from two participants who showed high concentrations of CH 3 SH. The internal regions of 16S rRNA genes were amplified using non-labeled 8F and 806R primers. Cloning of PCR amplicons was performed using a TOPO TA Cloning kit (Invitrogen, San Diego, CA, USA) in accordance with the manufacturer's instructions. A total of 100 colonies per participant were selected at random. The insert DNA from purified plasmids was sequenced with a BigDye Terminator v1.1 Cycle Sequencing kit (Applied Biosystems) and the M13 forward and reverse primer set. Using the BLAST program, obtained sequences were compared with the sequences in GenBank (www.ncbi.nlm.gov) (15) . Clone sequences with >98% identity with a GenBank sequence were considered to be derived from the species with the highest matching score. After identification of the best matches, T-RF sizes in clones were estimated by comparison with the 16S rRNA gene sequences of the closest reference.
Statistical analyses
Statistical analyses were carried out using SPSS v18 (SPSS Japan, Tokyo, Japan). Values of the mean and standard deviation of the clinical parameters for periodontal status were calculated. Parameters were compared among the three groups using the Kruskal-Wallis test. Changes in parameters of oral malodor, the TCS, and mean PARs of each peak in the T-RFLP profiles before and after treatment were analyzed using the Wilcoxon signed-rank test. A priori and post hoc power calculations were conducted using a stand-alone power analysis program (G*Power v.3.1.3, developed by Franz Faul at the University of Kiel, Kiel, Germany) and showed that our study had 44% power. Figure 1 shows a flow chart of participant enrolment. Two hundred twenty-eight patients were assessed for eligibility. Of these patients, 199 were excluded: 187 patients met the exclusion criteria, while the other 12 declined to participate. Twenty-nine patients were enrolled in the study and assigned randomly to one of three groups using computer-generated randomized numbers. No participants were excluded after enrollment. Clinical data for the participants, oral malodor and TCS at the baseline are shown in Tables 1 and 2 . Differences in clinical data, oral malodor and TCS between groups were not significant. A strong positive correlation existed between the CH 3 SH level and the ORS (r = 0.65) and between the levels of CH 3 SH and H 2 S (r = 0.60). A weak positive correlation was evident between the H 2 S level or CH 3 SH level and TCS (r = 0.34 or r = 0.37) at the baseline.
Results

Reduction of halitosis in a clinical trial of gargling treatment
After gargling, a significant reduction in oral malodor was observed in the test group when compared with the baseline scores ( Table 2) . Gargling with a mouthwash containing BZC markedly reduced the level of CH 3 SH from 91.3 ± 52.7 ppb to 53.6 ± 40.2 ppb (P = 0.013), and the level of H 2 S from 296.4 ± 161.6 ppb to 125.4 ± 113.6 ppb (P = 0.007). A significant decrease in the mean ORS (P = 0.027) in the test group was also observed. However, gargling did not affect the TCS even in the test group. 
Effects of gargling on tonsillar and salivary microbiota
To assess the influence of periodontal pathogens on halitosis, four VSC-producing bacterial species were detected in tonsil and saliva samples using real-time PCR, and the prevalence of each species was calculated. The proportions of periodontal pathogens did not differ significantly between groups at the baseline. Comparisons of the baseline percentages of periodontal pathogens in both types of samples with those after gargling revealed no significant changes in any of the groups (Table 3) . T-RFLP analyses were also carried out to ascertain if gargling affected the tonsillar and salivary microbiota. A comparison of the mean PAR of each representative T-RF before and after treatment is shown in Fig. 2 . The PAR for each T-RF in all three groups revealed no significant changes in either tonsillar or saliva samples. However, the PAR of H379 and H383 in the test group tended to decrease in response to treatment.
Cloning and sequencing for taxonomic assignment
Sequencing data for T-RFs of ~800 bp were obtained for ~100 clones from each sample, and 40 species were identified from these clones ( Table 4 ; the T-RF size of each bacterial species predicted from the sequence is indicated in the left column). A discrepancy between this size and T-RF size estimated on the basis of electrophoretic mobility was observed, as has been reported previously (16, 17) . On the basis of this discrepancy, some putative T-RFs were identified as candidates that were assigned to each phylotype. Candidate species assigned to T-RFs that were decreased in the test group, H379 and H383, were Neisseria perflava, Moraxella catarrhalis, Veillonella atypica, Chryseobacterium indologenes, and Prevotella and Alloprevotella species.
Discussion
It is well known that mouthwashes containing chlorhexidine (CHX) can help to reduce oral malodor. However, Significance of differences between saliva and pharynx samples was assessed by chi-squared test. Significance of differences among the three experimental groups was evaluated by Kruskal-Wallis test.
Fig. 2
Comparison of peak area rates of each representative T-RF at the baseline and after gargling (mean ± SE). Mean peak area rates for each representative T-RF are compared at the baseline (black column) and after gargling (white column).
Results for the test, placebo, and control groups for tonsillar samples are shown in panels A, B, and C, and those of the test, placebo, and control groups for saliva samples are shown in panels D, E, and F, respectively. There was no significant change in any representative T-RF, but H379 and H383 in the test group for tonsillar samples tended to decrease after treatment. Significance of differences was evaluated using the Wilcoxon signed-rank test.
use of CHX at a concentration of >0.05% on the oral mucosa is prohibited by the Japanese Pharmaceutical Affairs Law. In Japan, CHX-containing mouthwash products must use maximum CHX concentrations of 0.0005-0.002%, whereas the effective concentration of CHX for management of halitosis is 0.05-0.2% (18, 19) . Like CHX, BZC is a cationic surfactant and its positively charged polar heads seem to play a role in its antimicrobial action (20) . In Japan, BZC is one of the most widely used antiseptics for disinfection of the oral cavity and oropharyngeal regions (21) , and this is the first report of its antiseptic efficacy for treatment of oral malodor.
Coating of the tongue is the most common source of intra-oral halitosis, and tongue debridement is one of the most effective treatments for alleviating it (22) . In this study, however, removal of tongue coatings was prohibited during the test period to avoid any influence of active reduction of tongue biofilms on our results. Correlations between the levels of VSCs and the TCS were not strong at the baseline. Significant changes in the TCS were not observed despite gargling, whereas reductions in the levels of VSCs and the ORS were observed. The effects of antiseptic agents or mouthwashes on tongue coating contributing to halitosis have been controversial (23) reported that use of a mouthwash (0.05% CHX, 0.05% cetylpyridinium chloride, 0.14% zinc lactate) for 2 weeks significantly decreased oral malodor after rinsing, but did not affect the TCS, being roughly concordant with our results. In the present study, periodontal pathogens were detected in tonsil samples, but no inhibitory effect of gargling with BZC on these species was observed (similar results being observed in the placebo and control groups). This phenomenon may have been due to a low prevalence of periodontal pathogens in participants who did not have periodontitis. Consequently, bacterial species other than periodontal pathogens may have been associated with halitosis in these individuals.
The bacterial profile of the tonsillar microbiota analyzed by T-RFLP did not alter significantly after gargling, which suggests that tonsillar microbiota may not have been greatly influenced by use of BZC in the test period. However, comparison of the mean PAR of each T-RF showed that two T-RFs, H379 and H383, tended to change before and after gargling in the test group. The test period may have been too short to observe changes in microbiota consistent with biofilm formation. The results of putative taxonomic assignment suggested that Gramnegative species such as N. perflava, M. catarrhalis, V. atypica and C. indologenes, as well as Prevotella and Alloprevotella species, might be related to the reduction in halitosis after gargling with BZC. Prevotella species are obligate anaerobic Gram-negative rods known to contribute to oral malodor and CH 3 SH production (26, 27) . The novel genus Alloprevotella, which has recently branched from the genus Prevotella (28), has not been shown to be associated with halitosis. Veillonella species are representative VSC-producing bacteria. Takeshita et al. reported that Veillonella species showed high ratios of CH 3 SH:H 2 S (15, 16) . N. perflava, M. catarrhalis and C. indologenes are aerobic, Gram-negative bacteria often detected in the pharynx and airways as indigenous species (29, 30) , but they have not been reported to produce VSC.
This pilot study had some limitations in terms of significance because the sample size was smaller than the minimum estimated by power calculation (44% power) and VSC levels among the groups were not equivalent. Usually, a minimum sample size is required in order to avoid type II error or false negativity. Although our positive results with significant differences were considered to be appropriate, recruitment of more participants would have been desirable in order to conclude with certainty that our negative results were significant. Also it would have been better to use stratified block randomization to avoid non-equivalence of VSC levels between the groups.
We showed that gargling of the oropharynx area with an antiseptic reduced oral malodor in patients who did not have ENT-region disease. This finding suggests that management of the oropharyngeal microbiota may be an effective approach for treatment of halitosis, along with cleaning of the tongue and teeth. Although some bacterial species may be involved in the etiology of oral malodor, the bacterial profile in this area did not alter significantly after gargling. A further larger-scale study will be needed to clarify the role of bacteria in patients with halitosis and healthy tonsils, and the effects of gargling with antiseptic agents.
